NCT00458055View on ClinicalTrials.gov

High-Density Lipoprotein (HDL) Treatment Study

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Coronary ArteriosclerosisHypoalphalipoproteinemiasGenetic Diseases, Inborn
Interventions
DRUG

Atorvastatin; Fenofibrate; Niacin

Atorvastatin 20 mg; Fenofibrate 200 mg; Niacin 2g used sequentially for 8 weeks, after 4 weeks washout.

Trial Locations (1)

H3A 1A1

MUHC-Royal Victoria Hospital, Montreal

All Listed Sponsors
lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT00458055 - High-Density Lipoprotein (HDL) Treatment Study | Biotech Hunter | Biotech Hunter